// COMPANY
Parabilis Medicines
SECTOR BIOTECHMENTIONS 4LAST SEEN JUNE 11, 2026
Discussed in
// RECENT MENTIONS
// SIGNALS
4 SIGNALS
01
funding·PitchBook News·JUNE 11, 2026
“Parabilis Medicines has broken the record for the largest VC-backed biotech IPO, just weeks after Kailera Therapeutics took the crown.”
Source→02
mention·PitchBook News·JUNE 11, 2026
“Parabilis Medicines has broken the record for the largest VC-backed biotech IPO, just weeks after Kailera Therapeutics took the crown.”
Source→03
funding·Axios Pro Rata·JUNE 10, 2026
“Parabilis priced at $20 (vs. a $17–$19 range), raised $670M, and carries a $2.34B market cap at listing, backed by Fidelity (11.3%), RA Capital (10%), and Arch Venture Partners (8.3%).”
04
mention·Axios Pro Rata·JUNE 10, 2026
“The biotech market is in the midst of an IPO boom, after years of drought.”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.